605 related articles for article (PubMed ID: 26159364)
1. [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].
León-Pedroza JI; González-Tapia LA; del Olmo-Gil E; Castellanos-Rodríguez D; Escobedo G; González-Chávez A
Cir Cir; 2015; 83(6):543-51. PubMed ID: 26159364
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
3. [Immunometabolism of exercise and sedentary lifestyle].
Moreno-Eutimio MA; Acosta-Altamirano G
Cir Cir; 2014; 82(3):344-51. PubMed ID: 25238479
[TBL] [Abstract][Full Text] [Related]
4. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'?
Greenfield JR; Campbell LV
Curr Diabetes Rev; 2006 May; 2(2):195-211. PubMed ID: 18220627
[TBL] [Abstract][Full Text] [Related]
5. The evolving role of inflammation in obesity and the metabolic syndrome.
Lee YH; Pratley RE
Curr Diab Rep; 2005 Feb; 5(1):70-5. PubMed ID: 15663921
[TBL] [Abstract][Full Text] [Related]
6. Obesity, inflammation, and insulin resistance--a mini-review.
Zeyda M; Stulnig TM
Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, insulin resistance, and obesity.
Ferroni P; Basili S; Falco A; Davì G
Curr Atheroscler Rep; 2004 Nov; 6(6):424-31. PubMed ID: 15485587
[TBL] [Abstract][Full Text] [Related]
8. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis.
Wajchenberg BL; Nery M; Cunha MR; Silva ME
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):145-50. PubMed ID: 19466206
[TBL] [Abstract][Full Text] [Related]
10. [Obesity and inflammation].
Recasens M; Ricart W; Fernández-Real JM
Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
Sell H; Eckel J
Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
13. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
[No Abstract] [Full Text] [Related]
16. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
Robinson LE; Graham TE
Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
[TBL] [Abstract][Full Text] [Related]
17. Inflamed adipose tissue, insulin resistance and vascular injury.
Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U
Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581
[TBL] [Abstract][Full Text] [Related]
18. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer.
Matsuda M; Shimomura I
Obes Res Clin Pract; 2013; 7(5):e330-41. PubMed ID: 24455761
[TBL] [Abstract][Full Text] [Related]
19. Visceral fat and insulin resistance - what we know?
Janochova K; Haluzik M; Buzga M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
[TBL] [Abstract][Full Text] [Related]
20. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
